Introduction {#Sec1}
============

Colorectal cancer is the third most commonly diagnosed cancer and is the third leading cause of cancer-related deaths worldwide. In developing countries, the incidence of colorectal cancer has significantly increased \[[@CR1]\]. Anterior resection (AR), as known as Dixon operation, is the major surgical treatment for rectal cancer.

Anastomotic leakage (AL) is still the most dreaded surgical complication following AR, with an incidence rate of 1.6--20.5% \[[@CR2]--[@CR11]\]. AL is associated with increased postoperative mortality, length of hospitalization, and hospital-related costs. Some of the patients with AL may require a temporary or permanent stoma, which significantly affects patients' quality of life \[[@CR12]--[@CR15]\]. Furthermore, studies have shown that AL increases local recurrence rates and reduces cancer-specific survival \[[@CR12], [@CR16]\], which may be due to a delay of adjuvant therapy in patients with AL.

Many risk factors for anastomotic leakage have been reported; however, it is still difficult to predict anastomotic leakage accurately. Dekker et al. \[[@CR17]\] retrospectively analyzed the AL risk factors in 138 patients with left-sided colon cancer and developed an AL scoring system. Frasson et al. \[[@CR18]\] analyzed the AL risk factors in 3193 patients with colon cancer and created a devised nomogram to predict the risk of AL. However, the nomogram model can only be utilized in patients with colon cancer. Similarly, Yao et al. \[[@CR9]\] and Kim et al. \[[@CR19]\] constructed nomogram models as a tool for predicting the risk of AL after laparoscopic surgery of rectal cancer; however, the weights used in their reported nomogram models were different. To date, an accurate risk-predicting model for AL after AR has not been established.

The aim of this study was to create a precise and reliable nomogram for predicting the risk of AL after AR.

Materials and methods {#Sec2}
=====================

Patients {#Sec3}
--------

Patients who underwent AR at the Shanghai Cancer Center because of rectal cancer from January 2010 to February 2016 were included in our study. Exclusion criterion included a previous history of colon or rectal resection, and patients with tumors \> 12 cm from the anal verge were excluded. This study was approved by the Research Ethics Committee of the Cancer Hospital, Fudan University. Collection of patients' follow-up data was conducted in accordance with guidelines for the collection of human follow-up data from the Cancer Hospital, Fudan University. All patients provided written informed consent.

Overall, 2618 patients were finally recruited into our following analysis to establish the nomogram model. Then, 611 patients who underwent AR from March 2016 to April 2017 in our institution were prospectively collected as a group for external validation.

Definition of AL {#Sec4}
----------------

Clinical anastomotic leakage was considered to be present if any of the following were observed: gas or fecal discharge from the incisional wound, vagina, or the drain tract; fecal peritonitis; or intraabdominal abscess or peritonitis along with an anastomotic defect verified by image study, sigmoidoscopy, at laparotomy, or rectal examination. A pelvic abscess near the anastomotic site without an obvious fecal fistula was also classified as a clinical leakage \[[@CR4]\].

Based on the system proposed by the International Study Group of Rectal Cancer (ISREC), the degree of anastomotic leakage was classified into three categories: grade A required no active therapeutic intervention; grade B required active therapeutic intervention without the necessity of re-laparotomy; and grade C required re-laparotomy \[[@CR20]\]. In the present study, clinical AL was classified as grade B or C.

Statistical analysis {#Sec5}
--------------------

Patient-related, tumor-related, and surgery-related variables were collected as potential risk factors for AL in the univariate and multivariate analysis.

Most associations with AL, with regard to demographic and clinicopathologic features, were evaluated using multivariate logistic regression analysis. We used a stepwise selection method (sle = 0.05, sls = 0.10) to select a subset of all analyzed features. In the final model, only the features that were statistically significant at the 0.05 level were retained.

The nomogram performance was composed of two components: discrimination and calibration. The ability of a model to separate subject outcomes is known as discrimination. Discrimination was quantified with the concordance index (C-index), which is similar to the area under the receiver operating characteristic (ROC) curve \[[@CR21]\]. Calibration was performed by comparing the predicted probability of AL versus the actual probability of AL in all patients \[[@CR22]\], again using 500 bootstrap re-samples to reduce overfit bias, which would overstate the accuracy of the nomogram. We validated the nomograms with an external independent validation set, and the predictive performance was evaluated by the AUC value of the ROC analysis. Statistical analyses were performed using SPSS22.0, SAS 9.1, and R software version 3.1.2 (<http://www.r-project.org>) with the rms package. *P* values of 0.05 or lower were considered statistically significant.

Results {#Sec6}
=======

A total of 2618 patients were retrospectively collected as a training dataset. The incidence of clinical AL was 9.3% (243/2618), among which the incidence rates of grade B and grade C AL were 6.3% (165/2618) and 3.0% (78/2618), respectively. Additionally, 374 patients (14.3%) received neoadjuvant radio(chemo)therapy, 395 patients (15.1%) underwent laparoscopic surgery, and 444 patients (17.0%) underwent construction of a diverting stoma (DS) during the surgery.

The following variables were found to be associated with AL in univariate analysis: distance of tumor to anal verge, tumor size, duration of operation, preoperative hemoglobin level, blood loss, male, diabetes mellitus, bowel obstruction, ASA score, laparoscopic surgery, and anastomotic bleeding. The clinical information and results of the univariate analysis of patients in the training dataset are listed in Table [1](#Tab1){ref-type="table"}.Table 1Univariate analysis of variables related to anastomotic leakage (training dataset)Categorical variablesAll patients (*N* = 2618)Patients without AL (*N* = 2375)Patients with AL (*N* = 243)*P* valueContinuous variables Age, year (range)58.1 (22--93)58.1 (22--93)57.6 (22--81)0.557 BMI, kg/m^2^ (range)23.1 (14.6--38.3)23.1 (14.6--36.0)23.4 (15.8--38.3)0.055 Distance of tumor to anal verge, cm (range)11.2 (3--12)8.1 (3--12)7.2 (3--12)\< 0.001 Tumor size, cm (range)3.9 (0.5--14)3.9 (0.5--11)4.1 (0.8--14)0.029 Duration of operation, min (range)117.1 (23--481)116.1 (31--481)128.4 (23--292)\< 0.001 Preoperative hemoglobin, g/L130.4 (52--183)130.1 (52--183)133.2 (53--176)0.010 Preoperative albumin, g/L42.4 (26--54.4)42.4 (26--54.4)42.5 (29.4--54.3)0.493 Blood lost, mL (range)63.6 (0--1000)64.8 (0--1000)73.1 (0--1000)0.034 Perioperative blood transfusion, mL (range)6.1 (0--1000)6.0 (0--1000)7.0 (0--500)0.802Categorical variables of basic information Gender\< 0.001  Female1082102458  Male15361351185 Hypertension0.201  No20761891185  Yes54248458 Diabetes mellitus0.010  No23892178211  Yes22919732 Smoking habits0.146  Non-smoker21972001196  Smoker42137447 Alcohol excess0.051  No23842171213  Yes23420430 Bowel obstruction^a^\< 0.001  No25852352233  Yes332310 ASA score0.030  185175992  21192110389  327243 T stage0.114  Tis1521457  T123521817  T256150556  T368262062  T4a92483391  T4b645410 N stage0.382  N014961358138  N172264874  N240036931 M stage0.078  M024132182231  M120519312 Tumor stage (TNM-system)0.089  Tis1511447  I59753661  II67160863  III994894100  IV2051447Categorical variables of treatment details Neoadjuvant chemoradiation0.309  No22442041203  Yes37433440 Surgical approach0.017  Open22232004219  Laparoscopic39537124 Diverting stoma0.970  No21741972202  Yes44440341 Blood transfusion0.572  No25852346239  Yes33294 Anastomotic bleeding^b^\< 0.001  No25812354227  Yes372116 Combined left/right hemicolectomy0.079  No25922354238  Yes26215 Synchronous liver resection^c^0.311  No26082365243  Yes10100A two-tailed *P* value \< 0.05 was considered statistically significant*BMI*, body mass index; *ASA*, American Society of Anesthesiologists^a^Bowel obstruction was defined as obvious difficulty in defecation or radiologically confirmed obstruction and dilation of the proximal bowel^b^Anastomotic bleeding was defined as active bleeding at the anastomotic site before the end of surgery or postoperative blood stool with one or more of the following criteria: a significant fall in hemoglobin, need for blood transfusion, hemodynamic instability or shock and, finally, the need for any emergency intervention such as colonoscopy or surgery^c^Synchronous resection of both primary tumor and liver metastasis

The following variables were identified as independent risk factors of AL in multivariate analysis: gender (male) (*P* \< 0.0001, odds ratio (OR) = 2.286), distance of tumor to anal verge (*P* \< 0.0001, OR = 0.791), tumor size (*P* = 0.006, OR = 1.175), operating time (*P* \< 0.001, OR = 1.009), diabetes mellitus (*P* = 0.041, OR = 1.704), laparoscopic surgery (*P* = 0.004, OR = 0.445), anastomotic bleeding (*P* \< 0.001, OR = 13.46), diverting stoma (*P* \< 0.001, OR = 0.386) (Table [2](#Tab2){ref-type="table"}). A nomogram using these risk factors as weights is shown in Fig. [1](#Fig1){ref-type="fig"}.Table 2Factors associated with anastomotic leakage after anterior resection for rectal cancer by multivariate analysisAdjusted OR (95% CI)*P* valueGender (male)2.286 (1.484\~3.520)\< 0.0001Distance of tumor to anal verge0.791 (0.75\~0.864)\< 0.0001Tumor size1.175 (1.048\~1.318)0.006Duration of operation1.009 (1.005\~1.013)\< 0.001Diabetes mellitus1.704 (1.023\~2.837)0.041Surgical approach0.445 (0.255\~0.773)0.004Anastomotic bleeding13.46 (5.640\~31.63)\< 0.001Diverting stoma0.386 (0.234\~0.636)\< 0.001Fig. 1A nomogram for predicting postoperative anastomotic leakage after anterior resection for rectal cancer. To estimate the probability of AL in a given patient, mark patient values at each axis, draw a straight line perpendicular to the point axis, and sum the points for all variables. Then, we summed the total points and drew vertical line from the "total points" row to obtain the probability of anastomotic leakage

In the test dataset of 611 patients, the incidence of clinical AL was 10.5% (64/611). The incidence rates of grade B and grade C AL were 9.2% (56/611) and 1.3% (8/611), respectively. Additionally, 21.8% of these patients received neoadjuvant therapy (133/611), which was higher than 14.3% in the training dataset. In all, 43.4% (265/611) of these patients underwent laparoscopic surgery, which was higher than 15.1% in the training dataset. The incidence of DS in the test dataset was also higher than that in the training dataset (36.5% vs 17.0%, respectively). The reason for the differences between the two datasets dues to a more prevalent application of neoadjuvant therapy and laparoscopic surgery in our institution during the past few years, and patients who received neoadjuvant therapy or underwent low anterior resection (LAR) were more likely to receive a DS during surgery.

We validated the predicted efficiency of the created nomogram model using these 611 patients as a test dataset. The clinical information and identified risk factors associated with AL in the test dataset are listed in Table [3](#Tab3){ref-type="table"}. The nomogram that integrated all objective risk factors for AL is shown in Fig. [1](#Fig1){ref-type="fig"}. The C-index for AL prediction was 0.722 (0.720--0.724) in the model. The calibration plot for the incidence of AL showed an optimal agreement between the prediction by the nomogram and the actual observation (Fig. [2](#Fig2){ref-type="fig"}). ROC analysis confirmed the diagnostic potential of the nomogram. The model yielded an AUC of 0.723.Table 3Univariate analysis of variables related to anastomotic leakage (test dataset)Categorical variablesAll patients (*N* = 611)Patients without AL (*N* = 547)Patients with AL (*N* = 64)*P* valueContinuous variables Age, year (range)58.7 (24--86)58.7 (24--86)59.1 (30--82)0.789 BMI, kg/m^2^ (range)23.5 (15.4--36.6)23.5 (15.4--33.7)23.7 (15.6--36.6)0.572 Distance of tumor to anal verge, cm (range)8.0 (3.5--12.0)8.1 (3.5--12.0)7.7 (3.5--12.0)0.236 Tumor size, cm (range)4.0 (0.5--12.0)3.9 (0.5--12)4.2 (1.5--8.0)0.090 Duration of operation, min (range)108.9 (27--385)115.4 (28--385)126.5 (50--255)0.081 Preoperative hemoglobin, g/L131.9 (67--170)131.3 (67--169)131.8 (96--170)0.835 Preoperative albumin, g/L43.2 (29.4--52.3)43.3 (29.4--52.3)42.8 (34.9--50.4)0.353 Blood lost, mL (range)55.0 (5--1200)54.9 (5--1200)56.5 (5--150)0.841 Perioperative blood transfusion, mL (range)6.1 (0--1000)5.8 (0--1000)7.8 (0--500)0.811Categorical variables of basic information Gender\< 0.001  Male22821711  Female38333053 Hypertension0.078  No54248161  Yes69663 Diabetes mellitus\< 0.001  No57152150  Yes402614 Smoking habits0.424  Non-smoker52446757  Smoker87807 Alcohol excess0.899  No55149358  Yes60546 Bowel obstruction^a^\< 0.001  No57752354  Yes342410 ASA score0.316  120017327  238034535  324222 T stage0.185  Tis33294  T159527  T213011614  T378735  T4a28325033  T4b28271 N stage0.372  N036232042  N117015317  N279745 M stage0.714  M055249557  M159527 Tumor stage (TNM-system)0.676  Tis31274  I15313716  II14913019  III21920118  IV59527Categorical variables of treatment details Neoadjuvant chemoradiation0.536  No47842652  Yes13312112 Surgical approach0.462  Open34630739  Laparoscopic26524025 Diverting stoma0.860  No38834840  Yes22319924 Blood transfusion0.741  No60454163  Yes761 Anastomotic bleeding^b^\< 0.001  No59853959  Yes1385 Combined left/right hemicolectomy0.485  No60654363  Yes541 Synchronous liver resection^c^0.363  No60454064  Yes770A two-tailed *P* value \< 0.05 was considered statistically significant*BMI*, body mass index; *ASA*, American Society of Anesthesiologists^a^Bowel obstruction was defined as obvious difficulty in defecation, or radiologically confirmed obstruction and dilation of the proximal bowel^b^Anastomotic bleeding was defined as active bleeding at the anastomotic site before the end of surgery or postoperative blood stool with one or more of the following criteria: a significant fall in hemoglobin, need for blood transfusion, hemodynamic instability or shock and, finally, the need for any emergency intervention such as colonoscopy or surgery^c^Synchronous resection of both primary tumor and liver metastasisFig. 2**a** A calibration plot of the predicted and observed probabilities of anastomotic leakage after anterior resection for rectal cancer. The x-axis shows the predicted probability of anastomotic leakage, and the y-axis shows the observed probability of anastomotic leakage. The nomogram had a bootstrapped-concordance index of 0.72 and was well calibrated. **b** We validated the nomograms with an external independent validation set, and the receiver operating characteristic curve for the prediction model area under the curve was 0.723

Discussion and conclusion {#Sec7}
=========================

In this study, 2618 consecutive patients who underwent anterior resection for rectal cancer were collected to identify risk factors for anastomotic leakage. The multivariate analysis identifies the following variables as independent risk factors for anastomotic leakage: gender (male), distance of tumor to anal verge, tumor size, operating time, diabetes mellitus, laparoscopic surgery, anastomotic bleeding, and diverting stoma (Table [2](#Tab2){ref-type="table"}). We created a nomogram with high discriminative ability.

In previous studies, there were significant variations in the incidence rates of AL after colorectal resection, ranging from 1.6 to 20.5% \[[@CR2]--[@CR11]\]. In general, the incidence of AL increases after AR compared to colon surgery. In 2016, a prospective study by Park et al. \[[@CR23]\] showed AL rates of 5.6% (219/3912) and 1.1% (71/6565) after rectal and colon surgery, respectively. In addition, AL can be classified into asymptomatic subclinical AL and symptomatic clinical AL that requires active treatment. In 2009, ISREC classified AL into three grades (grades A, B, and C) based on its severity and required treatment regimens \[[@CR20]\]. In 2011, Maggiori et al. \[[@CR2]\] conducted a retrospective study that showed a total AL rate of 20.5% (41/200), of which 13.5% (27/200) accounted for clinical AL and 7% (14/200) for asymptomatic AL. In 2015, Shiomi et al. \[[@CR24]\] reported a total AL rate of 15.9% (149/936), of which 12.9% (121/936) accounted for grades B and C. In 2016, a prospective study by Qin et al. \[[@CR25]\] showed a total AL rate of 17.0% (54/318) after AR, with a clinical AL rate of 9.7% (31/318). However, most studies only included grades B and C. The significant difference in AL rates was attributable not only to the different ratios of the participants who underwent colon and rectal surgery but also to the inconsistent inclusion criteria for AL. In our center, the AL rates were relatively low: the incidence rate of grades B and C after resection was 6.83%, of which the incidence rates of grade B AL and grade C AL were 5.1% and 1.7%, respectively.

Our multivariate analysis showed that the postoperative risk for AL was significantly higher in male patients (adjusted OR = 2.29). Other studies obtained similar results (OR = 1.49--3.2) \[[@CR5], [@CR18], [@CR23], [@CR24]\]. The higher risk of AL in male patients may be due to their narrow pelvis, which leads to a more complicated operation compared to female patients with a broader pelvis. Some studies also showed that androgen might exert inhibitory effects on intestinal epithelial function. However, a significant association between sex and AL was not observed in other studies \[[@CR25], [@CR26]\]. Other patient-related risk factors, including medical history and preoperative nutritional status, were not found to be independent risk factors for AL in the present multivariate analysis.

Numerous studies found that the distance of the tumor or the anastomosis to the anal verge is closely associated with AL \[[@CR5], [@CR23], [@CR27]\]. However, these studies only classified the patients into two or three groups based on the distance from the anastomosis to the anal verge. For example, Yeh et al. \[[@CR4]\] and Jestin et al. \[[@CR28]\] showed a significant increase in AL risk when the distance between the anastomosis and the anal verge was less than 5--6 cm. Nevertheless, these studies could not accurately predict the corresponding risk of AL based on specific tumor locations. Our study identified the corresponding risk for AL based on specific tumor locations, and a nomogram model that could accurately identify the patients at high risk for AL was then created.

In previous studies, the association between tumor size and AL was investigated. A study by Park et al. \[[@CR29]\] showed that the AL rate was significantly higher in patients with tumor sizes \> 4 cm compared with those with tumor sizes \< 4 cm. In the studies conducted by Yun et al. \[[@CR10]\] and Koyama et al. \[[@CR7]\], the classification criteria were defined as 3 cm and 5 cm, respectively. However, no significant difference in AL risk was observed between the different groups. Nevertheless, all these studies reported higher AL rates in the patient groups with larger tumor sizes than in those with smaller tumor sizes. The absence of statistically significant differences in these studies might be due to their relatively small sample sizes. In this study, tumor size was considered a continuous variable for multivariate analysis, which showed that a larger tumor size was associated with a higher risk for AL.

The results of previous studies on whether intraoperative bleeding and blood transfusions increase the risk for AL have produced conflicting results \[[@CR7], [@CR24], [@CR27], [@CR28]\]. Our study showed that neither intraoperative bleeding nor blood transfusion increased the risk for AL. Only a few studies have investigated the relationship between AL and anastomotic bleeding, which was found in our study to be an independent risk factor for AL (adjusted OR = 11). Patients with anastomotic bleeding in both the training and validation cohorts had significantly higher risk for AL (*P* \< 0.001). Anastomotic bleeding may be caused by the poor quality of the stapling device or improper use of the stapling device. All these factors may lead to increased AL risk.

The effects of neoadjuvant therapy on AL after rectal cancer resection have been controversial. In early clinical studies, most neoadjuvant radiotherapies were short-course regimens. A meta-analysis that included 7 clinical studies (including 4 with short-course radiotherapy) concluded that neoadjuvant radiotherapy did not increase the risk for AL \[[@CR30]\]. With the increasing popularity of long-course radiotherapy as a neoadjuvant therapy, more recent clinical studies have shown that long-course neoadjuvant radiotherapy, particularly intensive chemoradiation therapy, increased the risk of AL \[[@CR5], [@CR28]\]. We believe that short-course radiotherapy does not cause significant bowel edema. In contrast, long-course radiotherapy, particularly intensive chemoradiation therapy, may cause significant bowel edema that increases the risk of AL. Therefore, whether the radiotherapy induced bowel edema and whether the anastomosis has been created in non-edematous areas during the surgery may be the reasons of the published discrepancy mentioned above.

A diverting stoma (DS) is often constructed to prevent AL. However, whether a DS can reduce the AL rate remains controversial. Some previous studies reported that a stoma could reduce severe anastomotic leakage and that a diverting stoma can diminish the severity of the leakage \[[@CR6], [@CR31]\]. In a study by Matthiessen et al. \[[@CR6]\], 234 patients who received LAR for rectal cancer were randomly assigned to undergo DS. The AL rate of patients with a DS was 10.3%, which is significantly lower than that in patients without a DS (28%). A meta-analysis \[[@CR32]\] which included 4 randomized controlled studies and 9 nonrandomized studies in 2015 showed that the risk of AL was significantly lower in patients with DS. However, Shiomi et al. \[[@CR24]\] found that the presence of a stoma could not reduce the incidence rate of AL but could reduce the reoperation rate by alleviating the clinical symptoms caused by AL. Wong et al. \[[@CR3]\] reported that a diverting stoma could not reduce grades B and C AL.

On the other hand, the impact of a DS on quality of life, such as an uncomfortable smell, the need for special care, prolapse at the stoma site, and fecal dermatitis, should not be ignored. Moreover, patients with DS are more likely to suffer from stenosis at the anastomotic site as well as significant morbidity and even mortality during stoma reversal. Several temporary stomas may become permanent \[[@CR13]\], especially in patients who received neoadjuvant radiochemotherapy. Thus, whether a protective stoma is necessary remains controversial. We recommend identifying high-risk patients who might need colostomy using our nomogram model, which will increase the selectivity of stoma creation among patients receiving AR.

Duration of surgery is also regarded as a risk factor in some previous studies \[[@CR8], [@CR9], [@CR17]\]. Our study also confirmed that patients with a longer duration of surgery had a higher risk of AL. The long duration of surgery may be caused by amateur surgical skill or poor exposure of the surgical field due to pelvic stenosis or large tumor. In addition, a decrease in blood perfusion caused by prolonged anesthesia may also increase the risk of AL.

Previous studies reported that diabetes mellitus (DM) was a risk factor for AL \[[@CR11], [@CR33]\]. We also got the same conclusion (OR, 1.7). The reasons why type 2 DM increased the risk of AL are as follows: insufficient blood supply to the anastomosis due to microcirculatory disorders, insufficient glycogen stores, and delayed tissue healing due to hyperglycemia. Therefore, patients with type 2 DM should be ensured that blood glucose is well controlled before surgery to reduce the risk of AL. However, several studies found that diabetes was not a risk factor for AL \[[@CR27], [@CR34]\].

Whether laparoscopic surgery increases the risk of anastomotic leakage is also controversial. Laparoscopic surgery does not reinforce the anastomosis conventionally, especially in low and ultralow anterior resection, which may increase the risk of anastomotic leakage. However, the CLASSIC study found that the incidence of AL was similar in laparoscopic and open surgery groups either in all enrolled patients (4% and 3%) or in the rectal cancer subgroup (8% and 7%) \[[@CR35], [@CR36]\]. Similarly, the COLORII study did not find that laparoscopic surgery increased the incidence of anastomotic leakage after radical resection of rectal cancer (12.6% and 10.4%, *P* = 0.462) \[[@CR37]\]. A meta-analysis including 11 nonrandomized controlled trials and 7 randomized controlled trials reported a 7.6% incidence of anastomotic leakage after laparoscopic surgery, with no significant difference compared with 8.9% of anastomotic leakage after open surgery \[[@CR38]\]. In our study, we found that laparoscopic surgery can reduce the incidence of anastomotic leakage. The reason may be explained by a better pelvis exposure of the surgical field, which leads to a better protection of the bowel in laparoscopic surgery.

This study had some limitations due to its retrospective nature. However, our nomogram could provide the surgeon with the precise probability of anastomotic leakage after low anterior resection for rectal cancer. Our nomogram can remind the surgeon to take precautions of patients with high AL risk. When patients with higher probability of anastomotic leakage are identified by the nomogram, they should be monitored carefully during the postoperative period. It might be helpful for them to delay removal of drainage tubes. In addition, the nomogram can also avoid an unnecessary DS in patients with low risk of AL, which reduces the quality of life and increases economic burden, as well as the risk of a permanent stoma. Our tools help to achieve more rational allocation of medical resources.

In conclusion, our study proved that a protective diverting stoma and laparoscopic surgery significantly decrease the risk of anastomotic leakage. Our nomogram was a useful tool for precise prediction of anastomotic leakage after anterior resection for rectal cancer.
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